Hebei Weimiao Biology Co., LTD 1
Location
  • Oseltamivir Phosphate Manufacturer - CAS 204255-11-8 | Quality Antiviral Solutions

ส.ค. . 29, 2024 04:13 Back to list

Oseltamivir Phosphate Manufacturer - CAS 204255-11-8 | Quality Antiviral Solutions



Oseltamivir phosphate, commonly known as Tamiflu, is an antiviral medication widely used for the treatment and prevention of influenza. Its chemical identification is associated with the CAS number 204255-11-8, which facilitates precise communication regarding the substance among researchers and healthcare professionals. This article explores the significance of oseltamivir phosphate, its manufacturer, and its implications in public health.

Oseltamivir phosphate, commonly known as Tamiflu, is an antiviral medication widely used for the treatment and prevention of influenza. Its chemical identification is associated with the CAS number 204255-11-8, which facilitates precise communication regarding the substance among researchers and healthcare professionals. This article explores the significance of oseltamivir phosphate, its manufacturer, and its implications in public health.


The primary manufacturer of oseltamivir phosphate is Roche, a multinational healthcare company based in Switzerland. Roche developed Tamiflu in collaboration with the biotechnology firm Gilead Sciences. Following its release, it quickly became the first line of defense against the flu and gained international prominence as the global response to influenza pandemics intensified. Roche has played a pivotal role in ensuring an adequate supply of the medication during flu seasons and health crises, such as the H1N1 pandemic in 2009.


cas 204255-11-8 oseltamivir phosphate manufacturer

<trp-post-container data-trp-post-id='8391'>Oseltamivir Phosphate Manufacturer - CAS 204255-11-8 | Quality Antiviral Solutions</trp-post-container>

In addition to its therapeutic applications, the manufacturing and production of oseltamivir phosphate are critical from a public health perspective. The ability to quickly scale up production in the event of a pandemic or widespread flu outbreak is essential. Consequently, regulatory agencies around the world have established frameworks to ensure the quality and safety of medicaments like oseltamivir.


Moreover, as antiviral resistance becomes a growing concern among healthcare providers, ongoing research and development are vital for monitoring oseltamivir’s effectiveness and discovering alternative treatments. Manufacturers and researchers alike are exploring ways to enhance the efficacy of oseltamivir and develop new antiviral agents to combat the ever-evolving flu virus.


In conclusion, oseltamivir phosphate, identified by the CAS number 204255-11-8, is an essential medication for managing influenza. The efforts of its manufacturer, Roche, in maintaining a steady supply and supporting public health initiatives underline the importance of collaboration in addressing infectious diseases. As the fight against influenza continues, the significance of oseltamivir and ongoing innovations in antiviral treatments remain paramount in safeguarding public health.


Share

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


thThai